Skip to search formSkip to main contentSkip to account menu

Femovan

National Institutes of Health

Related topics

Related topics

5 relations

Broader (3)

Combined Oral ContraceptivesEthinyl EstradiolNorpregnenes
FemodeneMinulet

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
1994
1994
Serum distribution of two contraceptive progestins: 3-ketodesogestrel and gestodene.
1994
1994
[Clinical observations using the new contraceptive preparation containing gestagen].
31 women aged 26-35 were observed during hormonal contraception with Femovan (in Poland registered as Femoden). The aim of the… 
1992
1992
Pharmacokinetics and protein binding of gestodene under treatment with a low-dose combination oral contraceptive for three months.
The serum concentrations of gestodene (CAS 60282-87-3) as well as the binding of this progestin to serum proteins were studied in… 
1992
1992
Pharmacokinetics and serum protein binding of gestodene and 3-keto-desogestrel in women after single oral administration of two different contraceptive formulations.
Two low-dose oral contraceptives, both containing the same dose of ethinyl estradiol (EE2, CAS 57-63-6) but different progestins… 
1991
1991
Klinische Erfahrungen mit Femovan
Gestoden ist als Kombinationspraparat mit Ethinylestradiol als orales Kontrazeptivum nach der Ersteinfuhrung in Deutschland 1987… 
1990
1990
Protein binding of active ingredients and comparison of serum ethinyl estradiol, sex hormone-binding globulin, corticosteroid-binding globulin, and cortisol levels in women using a combination of…
1990
1990
[Clinical experiences with femovan (Gynera)].
The low dose oral contraceptive Femovan/Gynera which contains 0.03 mg Ethinylestradiol and 0.075 mg Gestoden was examined in… 
1988
1988
[Drug therapy of dysmenorrhea].
Primary dysmenorrhea occurs mostly in young women with a painful bleeding pattern. In a recent study, 72% of 19-year-old women… 
Review
1988
Review
1988
[New progestational hormones].
The pharmacology and the application in oral hormonal contraceptives of four new progestogens--gestodene, desogestrel… 
1988
1988
New progestins focus on eliminating side effects.
A generation of progestins is being widely used in Europe, and experts predict these agents will eventually replace the… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)